Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARCT Arcturus Therapeutics Ltd.

休市中 12-12 16:00:00 EST

7.46

-0.06

-0.80%

盘后7.30

-0.16-2.14%

19:52 EST

最高7.62	最低7.33	成交量68.37万
今开7.52	昨收7.52	日振幅3.79%
总市值2.12亿	流通市值1.96亿	总股本2,841万
成交额511.49万	换手率2.60%	流通股本2,628万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":7.46,"timestamp":1765573200000,"preClose":7.52,"halted":0,"volume":683737,"hourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.46,"latestTime":"19:52 EST","volume":10389,"amount":77307.895,"timestamp":1765587151904},"delay":0,"floatShares":26275300,"shares":28412537,"eps":-2.46113,"marketStatus":"休市中","change":-0.06,"latestTime":"12-12 16:00:00 EST","open":7.52,"high":7.615,"low":7.33,"amount":5114927.5776959,"amplitude":0.037899,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.46113,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.52,"preHourTrading":{"tag":"盘前","latestPrice":7.6198,"preClose":7.52,"latestTime":"09:21 EST","volume":77,"amount":586.151027,"timestamp":1765549269148},"postHourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.46,"latestTime":"19:52 EST","volume":10389,"amount":77307.895,"timestamp":1765587151904},"volumeRatio":0.762977390195128,"impliedVol":0.8301,"impliedVolPercentile":0.364},"requestUrl":"/m/hq/s/ARCT","defaultTab":"news","newsList":[{"id":"1177153636","title":"Arcturus Therapeutics将在2025年11月10日发布第三季度财务结果并提供公司更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1177153636","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177153636?lang=zh_cn&edition=full","pubTime":"2025-10-29 04:02","pubTimestamp":1761681739,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics将在2025年11月10日发布第三季度财务结果并提供公司更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"gpt_icon":0},{"id":"1126056048","title":"Arcturus Therapeutics 股价下跌 56.6%，囊性纤维化药物初步分析未见改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1126056048","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126056048?lang=zh_cn&edition=full","pubTime":"2025-10-22 21:39","pubTimestamp":1761140348,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics 股价下跌 56.6%，囊性纤维化药物初步分析未见改善","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"gpt_icon":0},{"id":"1160945724","title":"Arcturus Therapeutics 股价在盘前暴跌52.6%，因吸入型mRNA治疗囊性纤维化的中期试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1160945724","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160945724?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:39","pubTimestamp":1761133158,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics 股价在盘前暴跌52.6%，因吸入型mRNA治疗囊性纤维化的中期试验结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"gpt_icon":0},{"id":"1140271252","title":"Arcturus Therapeutics Ltd. - Arct-032在I级囊性纤维化参与者中显示粘液栓块减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1140271252","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140271252?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:31","pubTimestamp":1761132672,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Ltd. - Arct-032在I级囊性纤维化参与者中显示粘液栓块减少","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"gpt_icon":0},{"id":"1122274269","title":"生物制药概念股普涨， APLT暴涨24%，LRMR涨16%，阿斯利康涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122274269","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122274269?lang=zh_cn&edition=full","pubTime":"2025-10-01 22:15","pubTimestamp":1759328132,"startTime":"0","endTime":"0","summary":"再生元制药公司涨6.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3953510fd7eeb47ed4578bf140220b88","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLT","ARCT","LRMR","AZN"],"gpt_icon":0},{"id":"2567190639","title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","url":"https://stock-news.laohu8.com/highlight/detail?id=2567190639","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567190639?lang=zh_cn&edition=full","pubTime":"2025-09-13 06:38","pubTimestamp":1757716705,"startTime":"0","endTime":"0","summary":"研发新冠疫苗的BioNTech盘中跌超10%、莫德纳跌超7%、Novavax跌超4%。投资者担心，如果特朗普政府进一步收紧疫苗接种政策，可能对疫苗制造商的业务造成重大冲击，特别是对莫德纳这类高度依赖新冠疫苗收入的公司。更新中","market":"us","thumbnail":"https://static.tigerbbs.com/632b4e916ff966270173f4303843021f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/632b4e916ff966270173f4303843021f"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3755508","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"ae8bc75ba4d1918dcafc0476d86c6d53","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3755508","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"生物科技股集体重挫！报道称特朗普政府将儿童死亡甩锅新冠疫苗接种","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["ARCT","TRVI","TVTX","AZN","NVAX","MRK","KALV","PGEN","TARS","NVS","MRNA","BK4009","BNTX","STRO","BMY","ABUS","PFE","SRPT","PSNL"],"gpt_icon":1},{"id":"1178671000","title":"Arcturus Therapeutics Ltd. - Meiji Seika Pharma公司的Kostaive mRNA疫苗在日本获得批准 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1178671000","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178671000?lang=zh_cn&edition=full","pubTime":"2025-08-29 18:12","pubTimestamp":1756462349,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Ltd. - Meiji Seika Pharma公司的Kostaive mRNA疫苗在日本获得批准 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"gpt_icon":0},{"id":"2550966215","title":"Arcturus Therapeutics Holdings Inc.盘中异动 大幅下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550966215?lang=zh_cn&edition=full","pubTime":"2025-07-12 03:30","pubTimestamp":1752262205,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日03时30分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价大幅跳水5.03%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Mink Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Calcimedica, Inc.涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为1131.42%、517.19%、91.09%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为721.86%、96.34%、86.50%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc是一家RNA药物公司，专注于罕见疾病的机会，目前专注于肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712033005a6a46038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712033005a6a46038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ARCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2539408583","title":"Arcturus Therapeutics(ARCT.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539408583","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539408583?lang=zh_cn&edition=full","pubTime":"2025-05-29 00:25","pubTimestamp":1748449528,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics(ARCT.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价32.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/29002550727846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2537925583","title":"Arcturus Therapeutics Holdings Inc.盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537925583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537925583?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:22","pubTimestamp":1747930967,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日00时22分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价大幅拉升5.02%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Vigil Neuroscience, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Instil Bio, Inc.涨幅较大，Polyrizon Ltd.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为4370.72%、2291.29%、874.76%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为64.32%、62.90%、60.20%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc是一家RNA药物公司，专注于罕见疾病的机会，目前专注于肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523002247976233bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523002247976233bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2537641071","title":"Arcturus Therapeutics Holdings Inc.盘中异动 快速拉升5.13%报12.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537641071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537641071?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:42","pubTimestamp":1747755776,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时42分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价大幅拉升5.13%。截至发稿，该股报12.61美元/股，成交量8.5658万股，换手率0.32%，振幅7.26%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc是一家RNA药物公司，专注于罕见疾病的机会，目前专注于肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234256aa2c9441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234256aa2c9441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2536638614","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.24%报12.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536638614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536638614?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:42","pubTimestamp":1747662179,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时42分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价急速拉升5.24%。截至发稿，该股报12.26美元/股，成交量1.9715万股，换手率0.07%，振幅6.18%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc是一家RNA药物公司，专注于罕见疾病的机会，目前专注于肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519214301a484262f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519214301a484262f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2536594141","title":"Arcturus Therapeutics Holdings Inc.2025财年第一财季实现净利润-14.08百万美元，同比增加47.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594141?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584048,"startTime":"0","endTime":"0","summary":"5月19日，Arcturus Therapeutics Holdings Inc.公布财报，公告显示公司2025财年第一财季净利润为-14.08百万美元，同比增加47.50%；其中营业收入为25.48百万美元，同比减少21.84%，每股基本收益为-0.52美元。机构评级：截至2025年5月19日，当前有9家机构对Arcturus Therapeutics Holdings Inc.目标价做出预测，其中目标均价为65.56美元，其中最低目标价为44.00美元，最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000234a482f04d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000234a482f04d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2518830278","title":"Arcturus Therapeutics Holdings Inc.盘中异动 急速下跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518830278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518830278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615845,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价急速跳水5.39%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3224.22%、699.68%、373.76%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Pmgc Holdings Inc.，振幅分别为41.36%、40.24%、32.14%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104598a2a73c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104598a2a73c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"gpt_icon":0},{"id":"2518028165","title":"Arcturus Therapeutics Holdings Inc.2024财年实现净利润-80.94百万美元，同比减少172.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518028165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518028165?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536075,"startTime":"0","endTime":"0","summary":"3月10日，Arcturus Therapeutics Holdings Inc.公布财报，公告显示公司2024财年净利润为-80.94百万美元，同比减少172.25%；其中营业收入为1.38亿美元，同比减少12.66%，每股基本收益为-3.00美元。机构评级：截至2025年3月10日，当前有8家机构对Arcturus Therapeutics Holdings Inc.目标价做出预测，其中目标均价为72.62美元，其中最低目标价为48.00美元，最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000234abf1756b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000234abf1756b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2517456003","title":"HC Wainwright & Co.：维持Arcturus Therapeutics(ARCT.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至60.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517456003","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517456003?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:52","pubTimestamp":1741369931,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Arcturus Therapeutics(ARCT.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至60.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08015248604974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"1138230349","title":"Arcturus Therapeutics 2024年第四季度GAAP每股收益$(1.11)，不及预期$(0.44)，销售额$22.800M，不及预期$44.650M","url":"https://stock-news.laohu8.com/highlight/detail?id=1138230349","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138230349?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:07","pubTimestamp":1741295246,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics报告季度亏损每股$，比分析师的共识预期$低152.27%。这一数据比去年同期的每股亏损$减少了246.88%。公司报告季度销售额为$22.800M，比分析师的共识预期$44.650M低48.94%。以上内容来自Benzinga Earnings专栏，原文如下：Arcturus $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 152.27 percent. This is a 246.88 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $22.800 million which missed the analyst consensus estimate of $44.650 million by","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2516540726","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516540726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516540726?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:34","pubTimestamp":1741026893,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时34分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速跳水5.15%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4398.57%、193.95%、179.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023453a25d8560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023453a25d8560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2516230136","title":"Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘大幅拉升5.04%报16.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516230136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516230136?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:51","pubTimestamp":1740775870,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时51分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速拉升5.04%。截至发稿，该股报16.87美元/股，成交量22.9722万股，换手率0.85%，振幅9.15%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010451119896c792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010451119896c792&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2513727043","title":"Arcturus Therapeutics Holdings Inc.盘中异动 快速下挫5.35%报16.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727043?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:53","pubTimestamp":1740408797,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时53分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速下跌5.35%。截至发稿，该股报16.82美元/股，成交量3.1745万股，换手率0.12%，振幅4.67%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242253179890fb11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242253179890fb11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":0.0463},{"period":"1month","weight":-0.0824},{"period":"3month","weight":-0.5693},{"period":"6month","weight":-0.3974},{"period":"1year","weight":-0.5749},{"period":"ytd","weight":-0.5604}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcturus Therapeutics Holdings Inc.在以色列注册，并于2008年2月7日开始运营。该公司是一家全球信使RNA药物公司，专注于开发针对肝脏和呼吸道罕见病的传染病疫苗和疗法。该公司正在利用专有的LUNAR平台和核酸技术，开发和推进一系列基于mRNA的疫苗和疗法，用于有重大未满足医疗需求的传染病和罕见遗传疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.073454},{"month":2,"riseRate":0.5,"avgChangeRate":0.009833},{"month":3,"riseRate":0.25,"avgChangeRate":-0.05017},{"month":4,"riseRate":0.583333,"avgChangeRate":0.110815},{"month":5,"riseRate":0.583333,"avgChangeRate":0.094979},{"month":6,"riseRate":0.615385,"avgChangeRate":0.024246},{"month":7,"riseRate":0.538462,"avgChangeRate":0.096382},{"month":8,"riseRate":0.538462,"avgChangeRate":0.072518},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.052457},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.077832},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033635},{"month":12,"riseRate":0.384615,"avgChangeRate":-0.049679}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}